Caris Life Sciences (CAI) Tax Provisions (2026)
Caris Life Sciences (CAI) posted quarterly Tax Provisions of -$134000.0 for Q1 2026.
Powered by 
Analysis
Caris Life Sciences (CAI) Tax Provisions (2026) Analysis & Trends
Caris Life Sciences' Tax Provisions history runs 1 years deep, the most recent figure standing at -$134000.0 for Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | - |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Caris Life Sciences | 6.99 Bn | 6.20 Bn | 182.38 Mn | 23,000.00 |